Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...
In a medical achievement that highlights how technology is reshaping modern healthcare, a surgeon in London has successfully carried out a complex cancer operation on a patient located roughly 1,500 ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...
The U.S. Food and Drug Administration on Friday approved a new ​formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ‌scanning access through increased production ...
The projections show the growing impact of lifestyle-related risk factors and gaps in early detection—while pointing to clear steps people can take now to reduce their risk. “These rising cancer rates ...
A new University of Kentucky study has mapped areas across the U.S. where high rates of diabetes and deaths from diabetes-related cancers overlap. The UK Markey Cancer Center and Barnstable Brown ...
Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...
ctDNA MRD testing may spot hidden relapse and guide treatment holidays in metastatic gastroesophageal cancer, as deep ctDNA drops predict longer PFS.
More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.An evaluation of 1-year ...
Komodo Health, the leader in AI-powered healthcare intelligence, today announced a strategic partnership with ZERO Prostate Cancer (ZERO), the nation’s leading prostate cancer advocacy and support ...